晚期慢性肾脏疾病患者的疾病感知。

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Miquel Sitjar-Suñer, Rosa Suñer-Soler, Afra Masià-Plana, Bernat Carles Serdà-Ferrer, Xavier Pericot-Mozo, Glòria Reig-Garcia
{"title":"晚期慢性肾脏疾病患者的疾病感知。","authors":"Miquel Sitjar-Suñer, Rosa Suñer-Soler, Afra Masià-Plana, Bernat Carles Serdà-Ferrer, Xavier Pericot-Mozo, Glòria Reig-Garcia","doi":"10.3390/jpm15030120","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/objectives</b>: Chronic kidney disease (CKD) has become an important public health issue; however, there are few investigations regarding the perception of CKD in its advanced stages. Personalized medicine approaches, which take into account knowledge of the disease, symptoms and treatment responses, can improve the perception of the disease and help control the progression of CKD. This study aimed to describe illness perception in people with advanced CKD in primary healthcare settings. <b>Methods</b>: A cross-sectional and multicenter descriptive study was conducted amongst a sample of 189 people over 18 years of age with advanced CKD and a glomerular filtration rate between 15 and 29 mL/min/1.73 m<sup>2</sup> in three community health centers, including rural and urban areas, during 2023. Data on sociodemographic and clinical variables were collected through an ad hoc questionnaire and those on the perception of disease through the Brief Illness Perception Questionnaire. Nurses at the centers collected data from the study. <b>Results</b>: The mean age was 79.7, and all participants suffered from another chronic condition in addition to CKD. The mean total score for perception of the disease was 44.02 points, and the dimensions of the duration of treatment control and understanding had the highest evaluations. Men had a greater perception in the dimensions of concern (<i>p</i> = 0.023) and understanding (<i>p</i> = 0.006). The dimension of consequences showed a correlation with identity (Spearman's Rho 0.688; <i>p</i> = 0.001), and concern about the disease was associated with emotional response (Spearman's Rho 0.689; <i>p</i> < 0.001). A higher number of hospital admissions was associated with a higher score on the questionnaire (B = 4.93; <i>p</i> < 0.001; CI: 3.01-6.84) in a multiple linear regression. <b>Conclusions</b>: Participants in this study with advanced CKD had low illness perception; women expressed less concern in understanding their health status. Higher symptom burden was linked to greater illness perception, greater emotional impact, and increased hospital admissions.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 3","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11943455/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Perception of Illness in People with Advanced Chronic Kidney Disease.\",\"authors\":\"Miquel Sitjar-Suñer, Rosa Suñer-Soler, Afra Masià-Plana, Bernat Carles Serdà-Ferrer, Xavier Pericot-Mozo, Glòria Reig-Garcia\",\"doi\":\"10.3390/jpm15030120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background/objectives</b>: Chronic kidney disease (CKD) has become an important public health issue; however, there are few investigations regarding the perception of CKD in its advanced stages. Personalized medicine approaches, which take into account knowledge of the disease, symptoms and treatment responses, can improve the perception of the disease and help control the progression of CKD. This study aimed to describe illness perception in people with advanced CKD in primary healthcare settings. <b>Methods</b>: A cross-sectional and multicenter descriptive study was conducted amongst a sample of 189 people over 18 years of age with advanced CKD and a glomerular filtration rate between 15 and 29 mL/min/1.73 m<sup>2</sup> in three community health centers, including rural and urban areas, during 2023. Data on sociodemographic and clinical variables were collected through an ad hoc questionnaire and those on the perception of disease through the Brief Illness Perception Questionnaire. Nurses at the centers collected data from the study. <b>Results</b>: The mean age was 79.7, and all participants suffered from another chronic condition in addition to CKD. The mean total score for perception of the disease was 44.02 points, and the dimensions of the duration of treatment control and understanding had the highest evaluations. Men had a greater perception in the dimensions of concern (<i>p</i> = 0.023) and understanding (<i>p</i> = 0.006). The dimension of consequences showed a correlation with identity (Spearman's Rho 0.688; <i>p</i> = 0.001), and concern about the disease was associated with emotional response (Spearman's Rho 0.689; <i>p</i> < 0.001). A higher number of hospital admissions was associated with a higher score on the questionnaire (B = 4.93; <i>p</i> < 0.001; CI: 3.01-6.84) in a multiple linear regression. <b>Conclusions</b>: Participants in this study with advanced CKD had low illness perception; women expressed less concern in understanding their health status. Higher symptom burden was linked to greater illness perception, greater emotional impact, and increased hospital admissions.</p>\",\"PeriodicalId\":16722,\"journal\":{\"name\":\"Journal of Personalized Medicine\",\"volume\":\"15 3\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11943455/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Personalized Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jpm15030120\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15030120","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:慢性肾脏疾病(CKD)已成为一个重要的公共卫生问题;然而,关于CKD晚期感知的研究很少。考虑到疾病、症状和治疗反应的个性化医疗方法可以提高对疾病的认识,并有助于控制CKD的进展。本研究旨在描述初级卫生保健机构中晚期CKD患者的疾病感知。方法:一项横断面和多中心描述性研究在三个社区卫生中心(包括农村和城市地区)的189名18岁以上晚期CKD患者中进行,肾小球滤过率在15至29 mL/min/1.73 m2之间。通过特设问卷收集社会人口学和临床变量数据,并通过简短疾病感知问卷收集疾病感知数据。这些中心的护士从研究中收集数据。结果:平均年龄为79.7岁,所有参与者除CKD外还患有其他慢性疾病。对疾病感知的平均总分为44.02分,治疗持续时间、控制和理解维度评价最高。男性在“关心”(p = 0.023)和“理解”(p = 0.006)两个维度上的感知能力更强。结果维度与同一性相关(Spearman’s Rho 0.688;p = 0.001),对疾病的担忧与情绪反应相关(Spearman’s Rho = 0.689;P < 0.001)。住院次数越多,问卷得分越高(B = 4.93;P < 0.001;CI: 3.01-6.84)在多元线性回归中。结论:本研究中晚期CKD患者的疾病感知较低;妇女对了解她们的健康状况表示较少关注。更高的症状负担与更大的疾病感知、更大的情绪影响和更多的住院率有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Perception of Illness in People with Advanced Chronic Kidney Disease.

Background/objectives: Chronic kidney disease (CKD) has become an important public health issue; however, there are few investigations regarding the perception of CKD in its advanced stages. Personalized medicine approaches, which take into account knowledge of the disease, symptoms and treatment responses, can improve the perception of the disease and help control the progression of CKD. This study aimed to describe illness perception in people with advanced CKD in primary healthcare settings. Methods: A cross-sectional and multicenter descriptive study was conducted amongst a sample of 189 people over 18 years of age with advanced CKD and a glomerular filtration rate between 15 and 29 mL/min/1.73 m2 in three community health centers, including rural and urban areas, during 2023. Data on sociodemographic and clinical variables were collected through an ad hoc questionnaire and those on the perception of disease through the Brief Illness Perception Questionnaire. Nurses at the centers collected data from the study. Results: The mean age was 79.7, and all participants suffered from another chronic condition in addition to CKD. The mean total score for perception of the disease was 44.02 points, and the dimensions of the duration of treatment control and understanding had the highest evaluations. Men had a greater perception in the dimensions of concern (p = 0.023) and understanding (p = 0.006). The dimension of consequences showed a correlation with identity (Spearman's Rho 0.688; p = 0.001), and concern about the disease was associated with emotional response (Spearman's Rho 0.689; p < 0.001). A higher number of hospital admissions was associated with a higher score on the questionnaire (B = 4.93; p < 0.001; CI: 3.01-6.84) in a multiple linear regression. Conclusions: Participants in this study with advanced CKD had low illness perception; women expressed less concern in understanding their health status. Higher symptom burden was linked to greater illness perception, greater emotional impact, and increased hospital admissions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信